Keyword: Johnson & Johnson
Abbott, Johnson & Johnson and 22 other organizations have told the FDA which medical device regulations they think the agency should scrap or revise.
The 30-startup hub will supersede the JLINX incubator J&J helped to set up at its R&D site in Beerse, Belgium.
Theravance will bring its GI drug through phase 2/3 in Crohn's disease and ulcerative colitis.
The collaboration gives Medopad access to the nearly 1 billion users of Tencent’s WeChat messaging service.
The past week ushered in discoveries that could inspire new treatments for Lyme disease and several cancers.
Arcturus Therapeutics VP Mark Herbert will take over as interim president after the ouster of Joseph Payne.
Sage committed to initiating sleep disorder trials of the GABA receptor modulator after getting a look at data from a study in healthy volunteers.
J&J began assessing whether to sell subsidiaries that make glucose meters, insulin pumps and other pieces of diabetes equipment last year.
The startup will use the series A funds to scale its predictive analytics platform while working to form partnerships with healthcare organizations.
Our panel discussed the meaning of good science and how different players can work together to leverage their respective strengths.